Cargando…
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors
No validated prognostic tool is available for predicting overall survival (OS) of patients with well-differentiated neuroendocrine tumors (WDNETs). This study, conducted in three independent cohorts of patients from five different European countries, aimed to develop and validate a classification pr...
Ejemplares similares
-
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study
por: Ricci, Angela Dalia, et al.
Publicado: (2022) -
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
por: Pusceddu, Sara, et al.
Publicado: (2022) -
SUN-136 Clinico-Pathological Features, Treatment Modalities and Survival of Patients with Malignant Insulinoma: A Multicenter Study
por: Veltroni, Alessio, et al.
Publicado: (2020) -
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Pusceddu, Sara, et al.
Publicado: (2019) -
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches
por: Niger, Monica, et al.
Publicado: (2020)